skip to main content

COVID-19 has fast-tracked and consolidated the adoption of healthcare information technology, or telehealth, into mainstream healthcare as face-to-face appointments became risky for patients and healthcare workers alike when the virus took hold.

In the blink of an eye, doctors’ appointments were delivered by video, electronic prescriptions became widespread and triage went online. Aside from the convenience it offers many patients, telehealth has also been creating efficiencies within healthcare systems as specialist services get accessed via video links. In addition, the technology has also been central to strategies for fighting the virus through contact tracing apps, for instance.

 

The cross-section of applications for telehealth found during the pandemic hints at the sector’s breadth and potential.

 

However, its rapid rise to prominence means that systems have not been integrated as carefully as they would have in normal times. Where largescale IT projects ordinarily take years to implement, the adoption of telehealth happened in a matter of weeks and months. The underlying risks associated with accelerated digital transformation on a massive scale in the sector range from privacy and data breaches to errors and omissions – all of which need to be addressed.

 

Read “The Great Telehealth Experiment” report to learn how the sudden rise in telehealth services during the pandemic has given patients and healthcare professionals a glimpse into the benefits of digital transformation, along with the risks that must be managed.

Key takeaways

  • The pandemic has fast-tracked telehealth into the mainstream.
  • Data compatibility issues between systems can undermine good projects.
  • Doctors need training to interpret all of the data they are now receiving.
  • Technology companies need to be careful when documenting project requirements under time pressure.
  • In the future, patients will have more health data at their fingertips and AI will play a big role in diagnosis.

The Great Telehealth Experiment

 

Read more reports in the ‘Life Science in the era of pandemics’ series:

Making Medical Devices During a Pandemic
Fighting COVID-19 with genomics
Emerging Risks in COVID-19 Clinical Trials
Lessons from the Supply Chain

© 2021 Chubb. All rights reserved.

No part of this article may be reproduced in any written, electronic, recording, or printed form without written permission of Chubb.

Disclaimer - The content of the above article is not intended to constitute professional advice. Although all content is believed to be accurate, Chubb Insurance Singapore Limited (Chubb) makes no warranty or guarantee about the accuracy, completeness, or adequacy of the content of this article. Users relying on any content do so at their own risk.

Tips and Resources

We help you stay ahead and informed with these helpful tips and tricks

Have a question or need more information?

Contact us to find out how we can help you get covered against potential risks